PL1917072T3 - Formulacja witaminowa - Google Patents

Formulacja witaminowa

Info

Publication number
PL1917072T3
PL1917072T3 PL06755917T PL06755917T PL1917072T3 PL 1917072 T3 PL1917072 T3 PL 1917072T3 PL 06755917 T PL06755917 T PL 06755917T PL 06755917 T PL06755917 T PL 06755917T PL 1917072 T3 PL1917072 T3 PL 1917072T3
Authority
PL
Poland
Prior art keywords
vitamin formulation
vitamin
formulation
Prior art date
Application number
PL06755917T
Other languages
English (en)
Inventor
Richard Buchta
Robert James Houlden
Rose Ye
Maria Larm
Leon Loupenok
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of PL1917072T3 publication Critical patent/PL1917072T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
PL06755917T 2005-06-01 2006-05-26 Formulacja witaminowa PL1917072T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68675205P 2005-06-01 2005-06-01
EP06755917A EP1917072B1 (en) 2005-06-01 2006-05-26 Vitamin formulation
PCT/IB2006/001392 WO2006129161A2 (en) 2005-06-01 2006-05-26 Vitamin formulation

Publications (1)

Publication Number Publication Date
PL1917072T3 true PL1917072T3 (pl) 2014-01-31

Family

ID=37482025

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12181456T PL2526930T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa
PL06755917T PL1917072T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12181456T PL2526930T3 (pl) 2005-06-01 2006-05-26 Formulacja witaminowa

Country Status (9)

Country Link
US (2) US8298515B2 (pl)
EP (2) EP2526930B1 (pl)
JP (1) JP5612263B2 (pl)
AU (1) AU2006253913B2 (pl)
CA (1) CA2611147C (pl)
ES (2) ES2407407T3 (pl)
NZ (1) NZ563560A (pl)
PL (2) PL2526930T3 (pl)
WO (1) WO2006129161A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP2526930B1 (en) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8076280B2 (en) * 2006-12-20 2011-12-13 Basf Se Emulsions containing encapsulated fragrances and personal care compositions comprising said emulsions
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CN102438590B (zh) * 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 局部泡沫组合物
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776474C (en) 2009-10-02 2021-01-12 Foamix Ltd. Topical tetracycline compositions
CN102770125B (zh) * 2009-12-22 2015-02-11 利奥制药有限公司 钙泊三醇一水化合物纳米晶体
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
RS53809B1 (en) 2010-06-11 2015-06-30 Leo Pharma A/S PHARMACEUTICAL COMPOSITION SKIN SPRAY CONTAINING VITAMIN D ANALYSIS AND CORTICOSTEROID
CA2802041A1 (en) 2010-06-11 2011-12-15 Precision Dermatology, Inc. High oil-content emollient aerosol foam compositions
PL2686017T3 (pl) 2011-03-14 2020-03-31 Drug Delivery Solutions Limited Kompozycja oftalmiczna
US8968790B2 (en) 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
CA2896429A1 (en) 2012-12-26 2014-07-03 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
EP3020392A4 (en) * 2013-07-11 2016-12-28 Pola Pharma Inc EXTERNAL USE COMPOSITION ADOPTING FOAMED CONDITION DURING USE
EP3065702B1 (en) 2013-10-31 2023-06-07 Sun Pharmaceutical Industries Ltd Topical pharmaceutical composition of acitretin
WO2015123239A1 (en) 2014-02-14 2015-08-20 Mission Pharmacal Company Spray delivery device
CA2936430C (en) 2014-02-14 2022-05-31 Mission Pharmacal Company Sprayable composition containing zinc oxide and a fluoro-olefin propellant
JP6499192B2 (ja) * 2014-02-14 2019-04-10 ミッション・ファーマカル・カンパニー 有効薬剤粒子を含む安定化されたスプレー可能なエマルション
JP2016204323A (ja) * 2015-04-27 2016-12-08 フジ日本精糖株式会社 骨形成促進剤
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
GB201815799D0 (en) * 2018-09-27 2018-11-14 Iiaa Ltd Skin analysis device

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330730A (en) * 1962-08-03 1967-07-11 Colgate Palmolive Co Pressurized emulsion quick breaking foam compositions
US3829563A (en) * 1972-11-30 1974-08-13 Hoffmann La Roche Emollient cleansing compositions
US3896789A (en) * 1974-06-10 1975-07-29 Riker Laboratories Inc Retinoic acid dipensing pressure sensitive dermotological tape
LU71012A1 (pl) * 1974-09-26 1976-08-19
US3988438A (en) * 1975-01-10 1976-10-26 American Cyanamid Company Hair conditioning shampoo
DE2543368A1 (de) 1975-09-29 1977-04-07 Vp Variopharm Gmbh Geschaeumte salbenfolie, verfahren zu ihrer herstellung und ihre verwendung
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4618344A (en) * 1982-06-01 1986-10-21 The Procter & Gamble Company Depilatory compositions
US4631064A (en) * 1982-06-01 1986-12-23 The Proctor & Gamble Company Depilatory compositions
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
DE3380923D1 (de) 1983-07-29 1990-01-11 Univ Duke Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
KR940010767B1 (ko) * 1985-08-02 1994-11-11 레오 파마슈티칼스 프로덕츠 리미티드 에이/에스(레벤스 케미스케 파브리크 프로덕션 사크티에셀스카브) 신규 비타민 d 동족체
WO1988001863A1 (en) 1986-09-12 1988-03-24 The Upjohn Company Foams for delivery of minoxidil
DE3702029A1 (de) * 1987-01-24 1988-08-04 Basf Ag Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung
EP0294914A3 (en) * 1987-03-17 1990-10-10 FISONS plc Nedocromil for the treatment of dermatological disorders
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
ATE108994T1 (de) 1987-09-23 1994-08-15 Oreal Hautbehandlungsmittel als aerosolschaum, das vaseline enthält.
US4981677A (en) 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US5143717A (en) * 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
CA2063576C (en) * 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
AU629670B2 (en) 1989-07-28 1992-10-08 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
KR930001805B1 (ko) * 1989-10-02 1993-03-13 브리스톨-마이어즈 스퀴브 컴페니 안정성이 개선된 트리티노인 유화크림 제제
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
US5037655A (en) * 1990-04-18 1991-08-06 Giovanoni Richard L Method of stabilizing tretinoin
DE69205466T2 (de) 1991-03-21 1996-05-30 Procter & Gamble Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten.
US5167950A (en) * 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5252331A (en) * 1992-03-05 1993-10-12 Lorenzo Freeman Less irritating shaving material
ATE192928T1 (de) * 1992-06-19 2000-06-15 Univ California Lipide zur epidermalen befeuchtung und zur wiederherstellung der barrierefunktion
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
SK279913B6 (sk) * 1993-09-01 1999-05-07 Teijin Limited Farmaceutický prostriedok vo forme krému
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
WO1995025715A1 (en) * 1994-03-24 1995-09-28 Ciba-Geigy Ag Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions
IL109230A (en) 1994-04-05 1998-08-16 Agis Ind 1983 Ltd Anti-fungal composition containing bifonazole and fluocinonide
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
GB9503119D0 (en) 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
GB9510162D0 (en) * 1995-05-19 1995-07-12 Bouras Elias Compositions for the treatment of skin conditions
FR2739555B1 (fr) * 1995-10-04 1998-01-02 Oreal Compositions cosmetiques photoprotectrices contenant des nanopigments de tio2 et un acylaminoacide
WO1997013518A1 (en) * 1995-10-10 1997-04-17 Marilyn Strube Treatment of pruritus with vitamin d and analogs thereof
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
GB9626794D0 (en) 1996-12-23 1997-02-12 Unilever Plc Antiperspirant or deodorant compositions
DE19631221C2 (de) * 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
ES2170522T5 (es) * 1997-08-18 2011-11-14 NEUBOURG SKIN CARE GMBH & CO. KG Crema cutánea espumosa.
BR9815384A (pt) 1997-10-02 2000-10-31 Oms Holdings Llc Composições de unguento em aerossol e método de fabricação
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
RO115938B1 (ro) * 1997-10-14 2000-08-30 Mihailescu C Gheorghe Offenbac Unguent dermatologic
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
JP3981525B2 (ja) * 1998-01-20 2007-09-26 ハワード・グリーン 組織への物質のトランスグルタミナーゼ連結
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
CN1152689C (zh) * 1998-03-04 2004-06-09 帝人株式会社 活性维生素d3乳状液类型的洗剂
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
EP0951897B1 (fr) * 1998-04-21 2003-09-03 L'oreal Composition à application topique contenant un copolymère d'oléfines à cristallisation contrôlée
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
BR122012030846B8 (pt) 1999-04-23 2021-05-25 Leo Pharma As composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma
US6524594B1 (en) * 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
US20050009717A1 (en) * 1999-07-01 2005-01-13 Lukenbach Elvin R. Foaming make-up removing cleansing compositions
US20020136757A1 (en) * 2000-01-28 2002-09-26 Samuel Baron Methods and devices for preventing transmission of sexually transmitted diseases
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
RU2271810C2 (ru) 2000-10-27 2006-03-20 Лео Фарма А/С Композиции местного применения, содержащие, по меньшей мере, один витамин d или один аналог витамина d и, по меньшей мере, один кортикостероид
CN1639329A (zh) * 2002-01-10 2005-07-13 特瓦制药工业有限公司 差向异构的维生素d类似物的选择性酶促酯化和溶剂解以及所述差向异构体的分离
PL208188B1 (pl) 2007-07-12 2011-03-31 Inst Farmaceutyczny Sposób otrzymywania kalcypotriolu
EP1461314A1 (en) * 2002-06-13 2004-09-29 Teva Pharmaceutical Industries Limited Epimerization of analogs of vitamin d
PL355298A1 (pl) * 2002-08-01 2004-02-09 DERMAPHYT Sp.z o.o. Preparat dermatologiczny do leczenia uszkodzesigma skóry
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20070292355A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20060233721A1 (en) 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20080317679A1 (en) 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
WO2004046097A1 (en) 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
CA2513773C (en) * 2003-01-24 2013-03-26 Connetics Australia Pty Ltd Clindamycin phosphate foam
JP2006525959A (ja) * 2003-02-05 2006-11-16 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ 水の存在に感受性の少なくとも一つの活性剤を含む逆エマルションタイプの組成物、並びに化粧品及び皮膚科学におけるその使用
BRPI0407373B1 (pt) * 2003-02-12 2015-04-22 Stiefel Res Australia Pty Ltd Composição de espuma hidroalcoólica fotoprotetora e formadora de filme resistente à água
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
CA2534372C (en) * 2003-08-04 2012-01-24 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
MY139521A (en) * 2004-03-18 2009-10-30 Leo Pharma As Stereoselective synthesis of vitamin d analogues
US20070299041A1 (en) 2004-05-26 2007-12-27 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
SE0401943D0 (sv) 2004-07-28 2004-07-28 Lipopeptide Ab New use
US7199278B2 (en) 2004-07-30 2007-04-03 Exxonmobil Chemical Patents Inc. Conversion of oxygenates to olefins
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
TWI397427B (zh) * 2004-08-31 2013-06-01 Stiefel Res Australia Pty Ltd 微乳化液、次微米乳化液的方法及組成物
TWI318203B (en) 2004-09-01 2009-12-11 Leo Pharma As Epimerization of allylic alcohols
PL207034B1 (pl) 2004-12-30 2010-10-29 Inst Farmaceutyczny Sposób wytwarzania bezwodnego kalcypotriolu
WO2006094064A2 (en) 2005-02-28 2006-09-08 Avocet Polymer Technologies, Inc. Method of reducing scars with vitamin d
EP2526930B1 (en) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
US20080153786A1 (en) 2006-05-22 2008-06-26 Galderma S.A. Controlled release of drugs into/through the skin
FR2887150B1 (fr) 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2889662B1 (fr) 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
US20080076742A1 (en) 2005-10-31 2008-03-27 Wisconsin Alumni Research Foundation Methods and compositions for treating diseases associated with neovascualrization
FR2892936A1 (fr) 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
FR2893847B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
FR2893845B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
WO2007070643A2 (en) 2005-12-14 2007-06-21 Zars, Inc. Compositions and methods for treating dermatological conditions
MX2008011557A (es) 2006-03-17 2008-12-09 Leo Pharma As Isomerizacion de intermediarios farmaceuticos.
MX2008012526A (es) 2006-03-31 2008-10-14 Stiefel Res Australia Pyt Ltd Gel espumoso en suspension.
WO2008038140A2 (en) 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
MX2009000507A (es) 2006-07-14 2009-06-12 Stiefel Res Australia Pty Ltd Espuma farmaceutica de acidos grasos.
EP1891944A1 (en) 2006-07-24 2008-02-27 Association pour la recherche à l'IGBMC (ARI) Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases
CN101534796B (zh) 2006-10-31 2014-09-17 株式会社钟化 含有生理活性物质的粒状组合物及其制备方法
EP2073794A2 (en) 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2008065514A2 (en) 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
ES2272198B1 (es) 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
WO2008089093A2 (en) 2007-01-12 2008-07-24 Quatrx Pharmaceuticals Company Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
EP1970048A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
WO2008128782A2 (en) 2007-04-24 2008-10-30 Dsm Ip Assets B.V. Photochemical process for the preparation of a previtamin d
WO2008128783A2 (en) 2007-04-24 2008-10-30 Dsm Ip Assets B.V. Photochemical process for the preparation of a previtamin d
US20080281755A1 (en) 2007-05-08 2008-11-13 Brown Stephen L System and method for providing commercial kitchen ventilation
WO2009057136A2 (en) 2007-08-03 2009-05-07 Glenmark Generics Limited Epimerization by stereoselective synthesis of vitamin d analogues
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
AU2006253913B2 (en) 2010-09-16
AU2006253913A1 (en) 2006-12-07
ES2447301T3 (es) 2014-03-11
JP2008542353A (ja) 2008-11-27
WO2006129161A3 (en) 2007-02-08
EP1917072A4 (en) 2010-10-13
EP1917072B1 (en) 2013-02-27
JP5612263B2 (ja) 2014-10-22
CA2611147A1 (en) 2006-12-07
EP1917072A2 (en) 2008-05-07
WO2006129161A2 (en) 2006-12-07
US20110014135A1 (en) 2011-01-20
EP2526930A1 (en) 2012-11-28
US20130101525A1 (en) 2013-04-25
ES2407407T3 (es) 2013-06-12
NZ563560A (en) 2009-11-27
US8629128B2 (en) 2014-01-14
US8298515B2 (en) 2012-10-30
EP2526930B1 (en) 2013-12-25
PL2526930T3 (pl) 2014-05-30
CA2611147C (en) 2013-04-09

Similar Documents

Publication Publication Date Title
PL1917072T3 (pl) Formulacja witaminowa
IL189856A0 (en) New formulation
GB2424581B (en) Formulations
TWI370115B (en) New formulation
PL1879451T3 (pl) Innowacyjna formulacja
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
HK1198914A1 (en) Novel dosage formulation
GB0526419D0 (en) Formulation
GB0505569D0 (en) Formulations
GB0517673D0 (en) Formulation
GB0423565D0 (en) Formulation
PL1855661T3 (pl) Preparaty zawierające awiptadil
GB0412530D0 (en) Formulation
EP1773354A4 (en) COMPOSITIONS OF VITAMIN B12
GB0518129D0 (en) Ramipril formulation
EP1889613A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING VITAMIN K
GB0501030D0 (en) Formulation
PL1928232T3 (pl) Stała formulacja
PT1855661E (pt) Formulações para aviptadil
GB0506035D0 (en) Improved formulation
GB0511169D0 (en) Vitamin E
GB0500807D0 (en) Formulation
GB0507811D0 (en) Formulation
GB0510788D0 (en) Formulation
GB0426142D0 (en) Formulation